Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
This medicine may be administered as 1 tablet once daily, regardless of meals, to patients with type 2 diabetes mellitus receiving concomitant sitagliptin 100mg and pioglitazone 15mg or 30mg.
Assessment of renal function is recommended before starting this medicine and periodically during treatment.
No dosage adjustment based on renal function is necessary if the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher.
Do not administer this medicine if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.
Improvement of glycemic control in patients with type 2 diabetes mellitus
View approved original textHide original text
This medicine is used to help control blood sugar in patients with type 2 diabetes who are suitable for combined administration of sitagliptin and pioglitazone. When taken along with dietary and exercise therapy, it helps effectively manage blood sugar. Therefore, it is used to improve blood sugar control in patients with type 2 diabetes.
Dosage and Administration
Adult dosage
This medicine may be administered as 1 tablet once daily, regardless of meals, to patients with type 2 diabetes mellitus receiving concomitant sitagliptin 100mg and pioglitazone 15mg or 30mg.
Assessment of renal function is recommended before starting this medicine and periodically during treatment.
No dosage adjustment based on renal function is necessary if the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher.
Do not administer this medicine if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73m2.
Precautions
This medicine consists of two components, sitagliptin and pioglitazone, and is used for the treatment of type 2 diabetes.
Sitagliptin helps to control blood sugar but may rarely cause serious allergic reactions, skin disorders, or pancreatitis, so symptoms should be carefully monitored during the first three months of administration.
Pioglitazone improves the action of insulin in the body but may pose risks for patients with heart failure; patients with symptoms of heart failure or a history of heart failure should not use this medicine.
Additionally, it is safe not to administer this medicine to patients with impaired kidney function or severely compromised liver function.
Women who are pregnant or may become pregnant, as well as patients with specific genetic lactose intolerance, should also avoid this medicine.
During treatment, special attention should be paid to symptoms of hypoglycemia, and the risk of hypoglycemia may increase when used with other diabetes medications.
If symptoms of heart failure such as swelling, difficulty breathing, or rapid weight gain occur while taking this medicine, you should immediately consult a healthcare professional.
If symptoms indicating liver dysfunction (fatigue, loss of appetite, jaundice, etc.) occur, you should immediately visit a hospital for examination, and discontinuation may be necessary based on liver function test results.
This medicine should not be administered to patients with a history of bladder cancer or active bladder cancer; if symptoms of bladder cancer (such as hematuria) occur, you should immediately inform your doctor.
It is important to regularly monitor blood sugar, liver function, and kidney function while taking this medicine, and to report any abnormal symptoms to healthcare professionals immediately.
Also, this medicine may interact with other medications, so you should inform your doctor or pharmacist about any other medications you are taking.
Side effects
Hypersensitivity reaction
anaphylaxis
angioedema
Stevens-Johnson syndrome
exfoliative skin disease
acute pancreatitis
congestive heart failure
heart failure
fluid retention
edema
Show 80 moreCollapse
hypoglycemia
upper respiratory tract infection
nasopharyngitis
headache
diarrhea
abdominal pain
nausea
constipation
vomiting
severe and disabling arthralgia
vesiculobullous dermatitis
myalgia
limb pain
back pain
interstitial lung disease
pruritus
thrombocytopenia
rhabdomyolysis
elevated liver enzymes
acute renal failure
pneumonia
diabetic complications
metabolic acidosis
falls
cardiac arrest
dyspepsia
dizziness
increased serum triglycerides
gastritis
weight loss
hypertension
hypernatremia
erectile dysfunction
vision impairment
diabetic macular edema
liver failure
weight gain
urinary tract infection
low back pain
dizziness
elevated serum creatine kinase
hypertension
worsening heart failure
cardiac dysfunction
orthostatic hypotension
palpitations
stroke
sexual dysfunction
myocardial infarction
fracture
elevated serum ALT
elevated serum AST
loss of appetite
upper abdominal pain
fatigue
weakness
nausea
dyspnea
itching
chest pain
tremors
chills
gastrointestinal disease
epigastric discomfort
numbness
muscle rigidity
head discomfort
worsening liver disease
urticaria
eczema
arthralgia
knee abnormalities
arm weakness syndrome
proteinuria
increased serum creatinine
anxiety
insomnia
drowsiness
simple herpes
blurred vision
Not everyone experiences these, and they can vary from person to person.
Storage
This medicine should be stored in a container that does not allow light and air to enter and should be kept away from humid places. It is important to maintain a storage temperature between 15 and 30 degrees.
Appearance and packaging
Appearance
Light orange rectangular film-coated tablets
Package unit
28 tablets/box [14 tablets/PTP x 2]
Same-ingredient medicines
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.